With operations across Asia, Europe, and North America, WuXi AppTec offers end-to-end solutions, including chemistry drug CRDMO and biology discovery services, to help customers advance healthcare products efficiently. Their open-access platform supports over 5,950 customers from 30+ countries, aiming to improve global health by enabling the development of groundbreaking treatments.